Perseus Proteomics Inc
TSE:4882

Watchlist Manager
Perseus Proteomics Inc Logo
Perseus Proteomics Inc
TSE:4882
Watchlist
Price: 642 JPY 0.47% Market Closed
Market Cap: 9.5B JPY
Have any thoughts about
Perseus Proteomics Inc?
Write Note

Intrinsic Value

Perseus Proteomics Inc's intrinsic value estimate is unreliable because it is based only on its multiples and doesn't use a DCF valuation.

The intrinsic value of one Perseus Proteomics Inc stock under the Base Case scenario is 760.55 JPY. Compared to the current market price of 642 JPY, Perseus Proteomics Inc is Undervalued by 16%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
760.55 JPY
Undervaluation 16%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Perseus Proteomics Inc

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for Perseus Proteomics Inc cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about Perseus Proteomics Inc?
Bearish
Neutral
Bullish

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Perseus Proteomics Inc

Provide an overview of the primary business activities
of Perseus Proteomics Inc.

What unique competitive advantages
does Perseus Proteomics Inc hold over its rivals?

What risks and challenges
does Perseus Proteomics Inc face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Perseus Proteomics Inc.

Provide P/S
for Perseus Proteomics Inc.

Provide P/E
for Perseus Proteomics Inc.

Provide P/OCF
for Perseus Proteomics Inc.

Provide P/FCFE
for Perseus Proteomics Inc.

Provide P/B
for Perseus Proteomics Inc.

Provide EV/S
for Perseus Proteomics Inc.

Provide EV/GP
for Perseus Proteomics Inc.

Provide EV/EBITDA
for Perseus Proteomics Inc.

Provide EV/EBIT
for Perseus Proteomics Inc.

Provide EV/OCF
for Perseus Proteomics Inc.

Provide EV/FCFF
for Perseus Proteomics Inc.

Provide EV/IC
for Perseus Proteomics Inc.

Show me price targets
for Perseus Proteomics Inc made by professional analysts.

What are the Revenue projections
for Perseus Proteomics Inc?

How accurate were the past Revenue estimates
for Perseus Proteomics Inc?

What are the Net Income projections
for Perseus Proteomics Inc?

How accurate were the past Net Income estimates
for Perseus Proteomics Inc?

What are the EPS projections
for Perseus Proteomics Inc?

How accurate were the past EPS estimates
for Perseus Proteomics Inc?

What are the EBIT projections
for Perseus Proteomics Inc?

How accurate were the past EBIT estimates
for Perseus Proteomics Inc?

Compare the revenue forecasts
for Perseus Proteomics Inc with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Perseus Proteomics Inc and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Perseus Proteomics Inc against its competitors.

Analyze the profit margins
(gross, operating, and net) of Perseus Proteomics Inc compared to its peers.

Compare the P/E ratios
of Perseus Proteomics Inc against its peers.

Discuss the investment returns and shareholder value creation
comparing Perseus Proteomics Inc with its peers.

Analyze the financial leverage
of Perseus Proteomics Inc compared to its main competitors.

Show all profitability ratios
for Perseus Proteomics Inc.

Provide ROE
for Perseus Proteomics Inc.

Provide ROA
for Perseus Proteomics Inc.

Provide ROIC
for Perseus Proteomics Inc.

Provide ROCE
for Perseus Proteomics Inc.

Provide Gross Margin
for Perseus Proteomics Inc.

Provide Operating Margin
for Perseus Proteomics Inc.

Provide Net Margin
for Perseus Proteomics Inc.

Provide FCF Margin
for Perseus Proteomics Inc.

Show all solvency ratios
for Perseus Proteomics Inc.

Provide D/E Ratio
for Perseus Proteomics Inc.

Provide D/A Ratio
for Perseus Proteomics Inc.

Provide Interest Coverage Ratio
for Perseus Proteomics Inc.

Provide Altman Z-Score Ratio
for Perseus Proteomics Inc.

Provide Quick Ratio
for Perseus Proteomics Inc.

Provide Current Ratio
for Perseus Proteomics Inc.

Provide Cash Ratio
for Perseus Proteomics Inc.

What is the historical Revenue growth
over the last 5 years for Perseus Proteomics Inc?

What is the historical Net Income growth
over the last 5 years for Perseus Proteomics Inc?

What is the current Free Cash Flow
of Perseus Proteomics Inc?

Discuss the annual earnings per share (EPS)
trend over the past five years for Perseus Proteomics Inc.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Perseus Proteomics Inc

Current Assets 2.2B
Cash & Short-Term Investments 2.1B
Receivables 18m
Other Current Assets 20.4m
Non-Current Assets 42.9m
Other Non-Current Assets 42.9m
Current Liabilities 108.5m
Accrued Liabilities 45.8m
Other Current Liabilities 62.7m
Non-Current Liabilities 191.5m
Other Non-Current Liabilities 191.5m
Efficiency

Earnings Waterfall
Perseus Proteomics Inc

Revenue
96.5m JPY
Cost of Revenue
-11.8m JPY
Gross Profit
84.6m JPY
Operating Expenses
-966.6m JPY
Operating Income
-882m JPY
Other Expenses
-19.5m JPY
Net Income
-901.5m JPY

Free Cash Flow Analysis
Perseus Proteomics Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Perseus Proteomics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional Revenue Growth Forecast
ROIC is Increasing
Positive 3-Years Revenue Growth
29/100
Profitability
Score

Perseus Proteomics Inc's profitability score is 29/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Perseus Proteomics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
Low D/E
81/100
Solvency
Score

Perseus Proteomics Inc's solvency score is 81/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Perseus Proteomics Inc

Wall Street analysts forecast Perseus Proteomics Inc stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Perseus Proteomics Inc is 816 JPY with a low forecast of 808 JPY and a high forecast of 840 JPY.

Lowest
Price Target
808 JPY
26% Upside
Average
Price Target
816 JPY
27% Upside
Highest
Price Target
840 JPY
31% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Perseus Proteomics Inc?

Click here to dive deeper.

Dividends

Perseus Proteomics Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for Perseus Proteomics Inc is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Perseus Proteomics Inc Logo
Perseus Proteomics Inc

Country

Japan

Industry

Biotechnology

Market Cap

9.1B JPY

Dividend Yield

0%

Description

Perseus Proteomics, Inc. is a holding company that develops antibody-based therapeutics and diagnostics. The company is headquartered in Meguro-Ku, Tokyo-To and currently employs 21 full-time employees. The company went IPO on 2021-06-22. The firm is involved in the research and development of therapeutic drugs for cancer and other diseases and related businesses. The firm is involved in the research, development, licensing, and manufacturing method establishment for commercialization in the fields of drug discovery, antibody research support, as well as antibody and reagent sales. The products include PPMX-T001, a therapeutic agent that targets glypican 3 (GPC3) present on the surface of cancer cell membranes; PPMX-T002, a therapeutic agent that targets cadherin 3 (CDH3) present on the surface of cancer cells; PPMX-T003, a therapeutic agent that targets the transferrin receptor (TfR); PPMX-T004 therapeutic agent targeting cadherin 3 (CDH3) and others.

Contact

TOKYO-TO
Meguro-ku
Park Bldg., 4-7-6, Komaba
+81357381705
www.ppmx.com

IPO

2021-06-22

Employees

21

Officers

President, CEO, Executive Officer & Chairman
Mr. Takuya Yokokawa
CTO & Executive Officer
Tadashi Matsuura
Head of Administrative Dept, Executive Officer & Director
Mr. Shinichi Suzukawa
Executive Officer, Head of R&D Dept., Head of Business Development Dept. and Director
Mr. Shinji Hagiwara

See Also

Discover More
What is the Intrinsic Value of one Perseus Proteomics Inc stock?

The intrinsic value of one Perseus Proteomics Inc stock under the Base Case scenario is 760.55 JPY.

Is Perseus Proteomics Inc stock undervalued or overvalued?

Compared to the current market price of 642 JPY, Perseus Proteomics Inc is Undervalued by 16%.

Back to Top